Candesartan vs Trastuzumab

Candesartan vs Trastuzumab: Overview

This comparison examines the pharmacological differences between Candesartan and Trastuzumab.

Mechanism of Action

Candesartan: Prodrug hydrolyzed to active form; selective angiotensin II type 1 receptor blocker.

Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

Pharmacokinetics

Half-life: Candesartan — 9 hours; Trastuzumab — 28 days.

Chemical Properties

Molecular Formula: Candesartan — C33H34N6O6.

Molecular Weight: Candesartan — 610.6640 g/mol.

Type: Candesartan — Small molecule; Trastuzumab — Antibody.